Susan Romanus
Keine laufenden Positionen mehr
Vermögen: 254 971 $ am 30.04.2024
Profil
Susan Romanus worked as a Senior Director & Compliance Officer at Merck Vaccine Division.
She then worked as Vice President, Chief Ethics & Compliance Officer at Daiichi Sankyo Co., Ltd.
Later, she worked as Chief Compliance & Quality Officer at ADC Therapeutics SA. Finally, she worked as Vice President-Compliance at Taiho Oncology, Inc. Ms. Romanus completed her undergraduate degree from the University of California San Diego and her MBA from the University of San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ADC THERAPEUTICS LTD
0,07% | 01.02.2023 | 57 426 ( 0,07% ) | 254 971 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Susan Romanus
| Unternehmen | Position | Ende |
|---|---|---|
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Compliance Officer | 01.01.2018 |
| DAIICHI SANKYO CO., LTD. | Compliance Officer | 01.01.2012 |
| Merck Vaccine Division | Compliance Officer | - |
| ADC THERAPEUTICS SA | Compliance Officer | - |
Ausbildung von Susan Romanus
| University of California San Diego | Undergraduate Degree |
| University of San Diego | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DAIICHI SANKYO CO., LTD. | Health Technology |
| ADC THERAPEUTICS SA | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Merck Vaccine Division | |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Health Technology |
